BAKNYSEIndustrial Organic ChemicalsFiscal year ends December 31
BRASKEM SA
Financials through fiscal 2024, year ended Dec 31, 2024
$1.70+0.04 (+2.41%)
Close on Oct 19, 2026
Margins
Share of revenue, fiscal years 2014 to 2024
Gross margin
7.7%−4.6 pts over 5 years
Operating margin
-1.4%−1.7 pts over 5 years
Net margin
-14.6%−9.8 pts over 5 years
Growth rates
Compound annual growth to fiscal 2024
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +9.7% | -9.8% | +8.1% | – | |
| Gross profit | +98.5% | -42.8% | -1.4% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2015 | FY2019 | FY2024 | Trend |
|---|---|---|---|---|
| Return on equity | – | -44.5% | 2865.8% | |
| Return on assets | – | -4.0% | -11.7% | |
| Current ratio | – | 1.44 | 1.31 | |
| Debt to equity | – | 7.67 | -13.64 | |
| Net debt to EBITDA | – | 8.10× | 12.98× | |
| Interest coverage | 2.2× | 0.0× | -0.2× | |
| Inventory turnover | – | 5.7× | 5.4× | |
| Capex to revenue | 7.1% | 5.1% | 4.9% | |
| Diluted shares | 796.05B | 796M | – |
Where the cash went
Fiscal 2020 to 2024, five years combined
Braskem generated 34.74B BRL from operations and spent 26.68B BRL on capital expenditure, dividends and share buybacks. 72% of that went back into the business.
Generated
34.74B BRL
Used
26.68B BRL
Capital expenditure19.32B BRL72%Dividends7.36B BRL28%Share buybacks0 BRL0%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-14.6%
×Asset turnover0.80×
×Equity multiplier-244.70×
=Return on equity, FY20242865.8%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2024 | -14.6% | 0.80× | -244.70× | 2865.8% |
| FY2023 | -6.5% | 0.79× | 15.89× | -80.9% |
| FY2022 | -0.3% | 1.07× | 11.89× | -4.4% |
| FY2021 | 13.2% | 1.18× | 31.54× | 493.9% |
| FY2020 | -11.4% | 0.76× | 57.48× | -498.8% |
| FY2019 | -4.9% | 0.82× | 11.12× | -44.5% |
| FY2018 | 4.9% | 1.04× | 8.69× | 44.1% |
| FY2017 | 7.8% | 0.94× | 11.57× | 85.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2024 against fiscal 2023
4of 8 tests passed in fiscal 2024. Some tests lack the figures they need.
- ProfitableNet income above zero-11.32B BRL
- Cash generatingOperating cash flow above zero2.44B BRL
- Return on assets improvedROA up on the prior year-5.2% → -12.3%
- Earnings backed by cashOperating cash flow above net income2.44B BRL vs -11.32B BRL
- Less leverageLong-term debt to assets fell43.8% → 50.2%
- Better liquidityCurrent ratio rose1.53 → 1.31
- No dilutionShare count did not rise– → –
- Gross margin improvedGross margin up on the prior year4.28% → 7.75%
- More efficientAsset turnover rose0.80 → 0.84